Eosinophilic cardiac disease: Molecular, clinical and imaging aspects

Archives of Cardiovascular Diseases

Volumn 108, Issue 4, 2015, Pages 258-268

  Séguéla, Pierre Emmanuel ^a   Iriart, Xavier ^a   Acar, Philippe ^b   Montaudon, Michel ^a   Roudaut, Raymond ^a   Thambo, Jean Benoit ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b HÔPITAL DES ENFANTS   (France)

Author keywords

DRESS syndrome; Endomyocardial fibrosis; Eosinophilia; Eosinophilic myocarditis; Restrictive cardiomyopathy

Indexed keywords

ARTICLE; CARDIOTOXICITY; CLINICAL FEATURE; ECHOCARDIOGRAPHY; EOSINOPHILIA; HEART DISEASE; HEART INJURY; HEART MUSCLE FIBROSIS; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; TRANSTHORACIC ECHOCARDIOGRAPHY; ANIMAL; BIOPSY; CARDIOMYOPATHIES; DIAGNOSTIC IMAGING; EOSINOPHIL; FIBROSIS; HEART MUSCLE; METABOLISM; NECROSIS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RISK FACTOR;

BIOLOGICAL MARKER;

ANIMALS; BIOMARKERS; BIOPSY; CARDIOMYOPATHIES; DIAGNOSTIC IMAGING; EOSINOPHILIA; EOSINOPHILS; FIBROSIS; HUMANS; MYOCARDIUM; NECROSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 84928585570     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2015.01.006     Document Type: Review

References (74)

1. Löffler W. Endocarditis parietalis fibroplastica mit bluteosinophilie. Ein eigenartiges Krankheitsbild. Schweiz Med Wochenschr 1936;66:817-20.
2. Lehrer RI, Szklarek D, Barton A, Ganz T, Hamann KJ, Gleich GJ. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol 1989;142:4428-34.
3. Shamri R, Xenakis JJ, Spencer LA. Eosinophils in innate immunity: an evolving story. Cell Tissue Res 2011;343:57-83.
4. Weller PF. The immunobiology of eosinophils. N Engl J Med 1991;324:1110-8.
5. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006;24:147-74.
6. Hogan SP, Rosenberg HF, Moqbel R, et al. Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 2008;38:709-50.
7. Séguéla PE, Acar P. Hypereosinophilic heart disease. In: da Cruz E, Ivy D, Jaggers J, editors. Pediatric and congenital cardiology, cardiac surgery and intensive care. London: Springer-Verlag; 2014. p. 2439-51.
8. Chusid MJ. Eosinophilia in childhood. Immunol Allergy Clin North Am 1999;19:327-46.
9. Rothenberg ME. Eosinophilia. N Engl J Med 1998;338:1592-600.
10. Sano K, Kobayashi M, Sakaguchi N, Ito M, Hotchi M, Matsumoto K. A rat model of hypereosinophilic syndrome. Pathol Int 2001;51:82-8.
11. Patella V, de Crescenzo G, Marino I, et al. Eosinophil granule proteins are selective activators of human heart mast cells. Int Arch Allergy Immunol 1997;113:200-2.
12. Gottdiener JS, Maron BJ, Schooley RT, Harley JB, Roberts WC, Fauci AS. Two-dimensional echocardiographic assessment of the idiopathic hypereosinophilic syndrome. Anatomic basis of mitral regurgitation and peripheral embolization. Circulation 1983;67:572-8.
13. Kahn JE, Bletry O, Guillevin L. Hypereosinophilic syndromes. Best Pract Res Clin Rheumatol 2008;22:863-82.
14. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-7.
15. Boccara F, Benhaiem-Sigaux N, Cohen A. Acute myopericarditis after diphtheria, tetanus, and polio vaccination. Chest 2001;120:671-2.
16. Cassimatis DC, Atwood JE, Engler RM, Linz PE, Grabenstein JD, Vernalis MN. Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol 2004;43:1503-10.
17. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975;54:1-27.
18. Katz HT, Haque SJ, Hsieh FH. Pediatric hypereosinophilic syndrome (HES) differs from adult HES. J Pediatr 2005;146:134-6.
19. Ogbogu PU, Bochner BS, Butterfield JH, et al. Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009;124, 1319-25e3.
20. Helbig G, Moskwa A, Hus M, et al. Heterogeneity among characteristics of hypereosinophilic syndromes. J Allergy Clin Immunol 2010;125, 1399-401e2.
21. Klion AD, Bochner BS, Gleich GJ, et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 2006;117:1292-302.
22. Stone RM, Gilliland DG, Klion AD. Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome. Semin Oncol 2004;31:12-7.
23. Ogbogu PU, Rosing DR, Horne 3rd MK. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007;27:457-75.
24. Eicher JC, Bonnotte B, L'Huillier I, et al. [Cardiovascular manifestations of eosinophilia: clinical and echocardiographic presentation]. Rev Med Interne 2009;30:1011-9.
25. Ginsberg F, Parrillo JE. Eosinophilic myocarditis. Heart Fail Clin 2005;1:419-29.
26. Corradi D, Vaglio A, Maestri R, et al. Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum Pathol 2004;35:1160-3.
27. Krous HF, Haas E, Chadwick AE, Wagner GN. Sudden death in a neonate with idiopathic eosinophilic endomyocarditis. Pediatr Dev Pathol 2005;8:587-92.
28. D'Orazio J, Pulliam J. Hypereosinophilic syndrome presenting as acute myocardial infarction in an adolescent. J Pediatr 2011;158:685.
29. Amini R, Nielsen C. Eosinophilic myocarditis mimicking acute coronary syndrome secondary to idiopathic hypereosinophilic syndrome: a case report. J Med Case Rep 2010;4:40.
30. Chun W, Grist TM, Kamp TJ, Warner TF, Christian TF. Images in cardiovascular medicine. Infiltrative eosinophilic myocarditis diagnosed and localized by cardiac magnetic resonance imaging. Circulation 2004;110:e19.
31. Aslan I, Fischer M, Laser KT, Haas NA. Eosinophilic myocarditis in an adolescent: a case report and review of the literature. Cardiol Young 2013;23:277-83.
32. May LJ, Patton DJ, Fruitman DS. The evolving approach to paediatric myocarditis: a review of the current literature. Cardiol Young 2011;21:241-51.
33. Yanagisawa T, Inomata T, Watanabe I, et al. Clinical significance of corticosteroid therapy for eosinophilic myocarditis. Int Heart J 2011;52:110-3.
34. Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS. Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest 1993;91:1721-30.
35. Kleinfeldt T, Nienaber CA, Kische S, et al. Cardiac manifestation of the hypereosinophilic syndrome: new insights. Clin Res Cardiol 2010;99:419-27.
36. Parrillo JE, Borer JS, Henry WL, Wolff SM, Fauci AS. The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med 1979;67:572-82.
37. Spry CJ, Davies J, Tai PC, Olsen EG, Oakley CM, Goodwin JF. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 1983;52:1-22.
38. Lofiego C, Ferlito M, Rocchi G, et al. Ventricular remodeling in Loeffler endocarditis: implications for therapeutic decision making. Eur J Heart Fail 2005;7:1023-6.
39. Sethi HS, Schmidley JW. Cerebral infarcts in the setting of eosinophilia: three cases and a discussion. Arch Neurol 2010;67:1275-7.
40. Korczyk D, Taylor G, McAlistair H, et al. Heart transplantation in a patient with endomyocardial fibrosis due to hypereosinophilic syndrome. Transplantation 2007;83:514-6.
41. Carnero-Alcazar M, Reguillo-Lacruz F, O'Connor F, Rodriguez-Hernandez E. Hypereosinophilic syndrome and myocardial fibrosis. Interact Cardiovasc Thorac Surg 2008;7:928-30.
42. Fuzellier JF, Chapoutot L, Torossian PF. Mitral valve repair in idiopathic hypereosinophilic syndrome. J Heart Valve Dis 2004;13:529-31.
43. Dedieu N, Giardini A, Khambadkone S, Marek J. Eosinophilic heart disease in a paediatric patient. Eur J Echocardiogr 2011;12:E3.
44. Assayag P, Carre F, Chevalier B, Delcayre C, Mansier P, Swynghedauw B. Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis. Cardiovasc Res 1997;34:439-44.
45. Paydar A, Ordovas KG, Reddy GP. Magnetic resonance imaging for endomyocardial fibrosis. Pediatr Cardiol 2008;29:1004-5.
46. Kleinfeldt T, Ince H, Nienaber CA. Hypereosinophilic Syndrome: a rare case of Löffler's endocarditis documented in cardiac MRI. Int J Cardiol 2011;149:e30-2.
47. Coelho-Filho OR, Mongeon FP, Mitchell RN, Blankstein R, Jerosch-Herold M, Kwong RY. Images in cardiovascular medicine. Löffler's endocarditis presenting with recurrent polymorphic ventricular tachycardia diagnosed by cardiac magnetic resonance imaging. Circulation 2010;122:96-9.
48. Francone M, Iacucci I, Mangia M, Carbone I. Endomyocardial disease related to idiopathic hypereosinophilic syndrome: a cardiac magnetic resonance evaluation. Pediatr Cardiol 2010;31:921-2.
49. Cherian G, Vijayaraghavan G, Krishnaswami S, et al. Endomyocardial fibrosis: report on the hemodynamic data in 29 patients and review of the results of surgery. Am Heart J 1983;105:659-66.
50. Bell JA, Jenkins BS, Webb-Peploe MM. Clinical, haemodynamic, and angiographic findings in Löffler's eosinophilic endocarditis. Br Heart J 1976;38:541-8.
51. Eroglu E, Di Salvo G, Herbots L, Herregods MC, Sutherland GR. Restrictive left ventricular filling in hypereosinophilic syndrome as a result of partial cavity obliteration by an apical mass: a strain/strain rate study. J Am Soc Echocardiogr 2003;16:1088-90.
52. Lepley Jr D, Aris A, Korns ME, Walker JA, D'Cunha RM. Endomyocardial fibrosis. A surgical approach. Ann Thorac Surg 1974;18:626-33.
53. Dubost C, Chapelon C, Deloche A, et al. [Surgery of endomyocardial fibrosis. A propos of 32 cases]. Arch Mal Coeur Vaiss 1990;83:481-6.
54. Moraes F, Lapa C, Hazin S, Tenorio E, Gomes C, Moraes CR. Surgery for endomyocardial fibrosis revisited. Eur J Cardiothorac Surg 1999;15:309-12, discussion 12-3.
55. Metras D, Coulibaly AO, Ouattara K. The surgical treatment of endomyocardial fibrosis: results in 55 patients. Circulation 1985;72:II274-9.
56. Tang A, Karski J, Butany J, David T. Severe mitral regurgitation in acute eosinophilic endomyocarditis: repair or replacement? Interact Cardiovasc Thorac Surg 2004;3:406-8.
57. Fuzellier JF, Chapoutot L, Torossian PF, Metz D, Baehrel B. Mitral valve replacement in idiopathic eosinophilic endocarditis without peripheral eosinophilia. J Card Surg 2005;20:472-4.
58. Watanabe K, Tournilhac O, Camilleri LF. Recurrent thrombosis of prosthetic mitral valve in idiopathic hypereosinophilic syndrome. J Heart Valve Dis 2002;11:447-9.
59. Spodick DH. Eosinophilic pericarditis caused by minocycline. Postgrad Med J 2001;77:215.
60. Spiegel R, Miron D, Fink D, Gavriel H, Horovitz Y. Eosinophilic pericarditis: a rare complication of idiopathic hypereosinophilic syndrome in a child. Pediatr Cardiol 2004;25:690-2.
61. Fernandez AB, Ahmed S, Duncan B, Firshein S, Kluger J. Cardiac tamponade: a rare complication of idiopathic hypereosinophilic syndrome. J Cardiovasc Med (Hagerstown) 2009;10:188-91.
62. Virmani R, Chun PK, Dunn BE, Hartmen D, McAllister HA. Eosinophilic constrictive pericarditis. Am Heart J 1984;107:803-7.
63. Kounis NG, Mazarakis A, Tsigkas G. Eosinophilic coronary periarteritis presenting with vasospastic angina and sudden death: a new cause and manifestation of Kounis syndrome? Virchows Arch 2013;462:687-8.
64. Kajihara H, Tachiyama Y, Hirose T, et al. Eosinophilic coronary periarteritis (vasospastic angina and sudden death), a new type of coronary arteritis: report of seven autopsy cases and a review of the literature. Virchows Arch 2013;462:239-48.
65. Taira K, Tsunoda R, Watanabe T, Fujino A, Ogyu A, Ashikawa K. An autopsy case of isolated eosinophilic coronary periarteritis: a limited form of Churg-Strauss syndrome or a new entity? Intern Med 2005;44:586-9.
66. Pick RA, Glover MU, Vieweg WV. Myocardial infarction in a young woman with isolated coronary arteritis. Chest 1982;82:378-80.
67. Cassling RS, Lortz JB, Olson DR, Hubbard TF, McManus BM. Fatal vasculitis (periarteritis nodosa) of the coronary arteries: angiographic ambiguities and absence of aneurysms at autopsy.J Am Coll Cardiol 1985;6:707-14.
68. Bukhman G, Ziegler J, Parry E. Endomyocardial fibrosis: still a mystery after 60 years. PLoS Negl Trop Dis 2008;2:e97.
69. Davies JN. Endomyocardial fibrosis in Uganda. East Afr Med J 1948;25:10-6.
70. Davies J, Spry CJ, Vijayaraghavan G, De Souza JA. A comparison of the clinical and cardiological features of endomyocardial disease in temperate and tropical regions. Postgrad Med J 1983;59:179-85.
71. Andy JJ. Aetiology of endomyocardial fibrosis (EMF). West Afr J Med 2001;20:199-207.
72. Andy JJ, Ogunowo PO, Akpan NA, Odigwe CO, Ekanem IA, Esin RA. Helminth associated hypereosinophilia and tropical endomyocardial fibrosis (EMF) in Nigeria. Acta Trop 1998;69:127-40.
73. Brockington IF, Olsen EG, Goodwin JF. Endomyocardial fibrosis in Europeans resident in tropical Africa. Lancet 1967;1:583-8.
74. Cilliers AM, Adams PE, Mocumbi AO. Early presentation of endomyocardial fibrosis in a 22-month-old child: a case report. Cardiol Young 2011;21:101-3.